GlassScriptPhysician profile
Keith Andrew Fehring
NPI 1861629149
$664,757.67
in general payments reported to CMS, 2019-2025
19 companies · $127K in 2025
The $127K reported for 2025 was more than what 97% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $79K · 2020: $61K · 2021: $69K · 2022: $103K · 2023: $195K · 2024: $29K · 2025: $127K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $205K · Consulting Fee: $96K · Education: $38K · Travel and Lodging: $8,892 · Food and Beverage: $3,708.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $204,980.55 |
| Consulting Fee | $96,355.51 |
| Education | $37,850.00 |
| Travel and Lodging | $8,891.96 |
| Food and Beverage | $3,708.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $291,035.42 | 2019-2025 | Attune |
| Medical Device Business Services, INC. | $270,688.82 | 2019-2025 | Attune, Lps, S-Rom Noiles |
| Zimmer Biomet Holdings, INC. | $99,107.18 | 2019-2025 | Z1 Hip System, G7, Arcos |
| Arthrex, INC. | $1,162.22 | 2019 | |
| Depuy Synthes Sales INC. | $594.15 | 2019-2024 | Na, Dynaforce |
| Smith+Nephew, INC. | $496.69 | 2021-2025 | Legion Revision, Real Intelligence, Renasys Touch |
| Encore Medical, LP | $227.05 | 2022 | |
| Lima USA, INC. | $171.37 | 2019 | |
| Intellijoint Surgical INC. | $168.35 | 2024 | Intellijoint Hip |
| Bone Support INC. | $162.42 | 2019 | |
| Peerless Surgical INC. | $153.13 | 2019-2020 | |
| Medacta USA, INC. | $147.59 | 2022 | |
| Medtronic, INC. | $145.66 | 2024 | Plasmablade(Tm) |
| Next Science LLC | $132.07 | 2021 | |
| Heraeus Medical, LLC. | $115.95 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $108.50 | 2019 | |
| Osteoremedies, LLC | $100.69 | 2024 | Biowash Surgical Irrigation, Biobrush, Osteoboost Select 10cc |
| Stryker Corporation | $25.91 | 2021 | |
| Molnlycke Health Care US, LLC | $14.50 | 2025 | Mepilex Border Post-Op Ag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Fehring listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.